Harrington-MSTP at CWRU
Harrington-MSTP at CWRU supports CWRU MD/PhD students with research funding and drug development expertise to advance innovative discoveries toward medical therapies addressing unmet needs.
Funder: Harrington Discovery Institute
Due Dates: September 30, 2026 (LOI call opens) | November 16, 2026 (LOI deadline) | January 18, 2027 (Invited full applications) | April 2027 (Scholar announcement)
Funding Amounts: Up to $100,000 for one year, with an opportunity to qualify for up to $750,000/program at commercially viable milestones
Summary: Supports CWRU MD/PhD students advancing innovative discoveries toward medical therapies through research funding and drug development expertise.
Key Information: Applicants must be enrolled in CWRU’s Medical Scientist Training Program; later-starting projects require discussion with the MSTP Director before applying.
Description
Harrington-MSTP at CWRU is a collaboration between Harrington Discovery Institute and Case Western Reserve School of Medicine supporting young physician-scientists whose research could progress from scientific discovery to a medical therapy. The award recognizes students’ own innovative and creative work, with a focus on breakthrough discoveries addressing unmet medical needs.
The program seeks modulators of novel targets and discoveries with strong intellectual property or a protection strategy. Projects may involve small molecules, biologics or other therapeutic modalities; diagnostics and devices should be part of a therapeutic development project. Alongside milestone-driven funding, scholars receive drug development expertise, project management support, and advice on business, commercialization and clinical development. The program also connects scholars with a community of physician-scientist innovators.
